BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Panacos Attracts $18.3M Round To Fund HIV Drug Development (BioWorld Today)
News | 04. 16. 2008
Panacos Pharmaceuticals
Panacos Pharmaceuticals Inc. raised $18.3 million in its Series C round of financing.
